Corporate Webpages Zimmer Holdings Inc.
Our traders are aging rapidly, as Zenith has been around for a
very long time. They were experimenting with computers while
Bill Gates was still in swadling clothes. Of course, technology
has since soared past them. With aging comes surprises. We
have direct experience with aches and pains of old age which are
extremely difficult to diagnose. When arthritis, bone density,
and circulation problems are rule out as the cause of pain, what
is left? Yet there it is, in shoulders, hips and knees,
especially the knees. Doctors some up with all sorts of bizarre
diagnoses, everything from crossed nerve fibers sending the
wrong messages to the brain to the requirement to wear knee
pads. Perhaps the most bizarre diagnosis of all is, "You've
been seeing too many doctors!"
Zimmer Holdings offers hope to folks like us. Most of the lay
people with whom we have talked swear by various implant
treatments they got, and Zimmer is king in the manufacture of those.
Frankly, we've been a little disappointed in some of the recent
stock selections we've set out to review. We think Market
Grader, Street.Com and E-Trade did not do a very good job of
pointing us to satisfactory issues. But one tried and true
source of recommendations is Morningstar. We feel a little more
confident of Morningstar because it doesn't rate all stock with
a mindless computer program, but actually employs analysts to
look thoroughly at the companies they review. And Morningstar
puts Zimmer Holdings at the top of its rating list.
Zimmer is a spinoff from Bristol-Myers Squibb. The spinoff
occurred in 2001. It is in the S&P 500 Index. Zimmer had
operated fairly autonomously under Bristol-Myers and traces its
roots back to 1927. After the spinoff, Zimmer was free to
pursue acqusitions with the proceeds of its initial public offering.
This it did vigorously. The number of people aging in America
is a positive for Zimmer as more and more people will suffer the
"surprises" of sudden attacks of crippling arthritis. Zimmer became
really big when it bought out Swiss medical implant maker, Centerpulse
for $3.2 billion.
A problem for all aritificial hip and knee makers arose in 2007,
when companies began to offer kickbacks to doctors for using
their products. Zimmer, to stay competitive, was one of these.
Of the "big five" medical device implant makers, Zimmer was
fined the most, $199.5 million, by the Department of Justice.
Anti-kickback statutes were on the federal books, and ability to
receive Medicare payments hinged upon compliance.
We like this company, although we note that analysts are
skittish and institutions and mutual funds are selling more than
they are buying. Still, the company looks large and solid to
us, relatively risk-free. Its stock share price has been as
high as $90 before the recent stock market meltdown, and it has
resisted the decline about as well as anybody, looking at stable
earnings and growth prospects. It offers training for doctors,
and this usually leads those doctors to use its products, just
as IBM-trained IT people use systems they are familiar with, or
electronic or lighting engineers use products supplied by
companies which offer technical expertise assistance.
10-30-2009: Zimmer Holdings Inc. (ZMH): Solid, Relevant, and Sound
(WAIT FOR PAGE TO LOAD COMPLETELY BEFORE LINKS WORK.)
Company Profile
Company History
News
Comparison with Peers
Bond Issue
Zenith Index
Financial Statements
Financial Ratios
Market Grader
Intrinsic Value (Disc. CashFlow)
Intrinsic Value (Proj. Earnings)
Scout Stock Rating
Projected Earnings
Research Reports
Analysts' Opinions
Insider Activity
Institutional Activity
Sentiment
Short Interest
Stock Report
Management's Discussion
Moving Average Chart
Channel Potential
Intraday Chart
Stock Fetcher
Point & Figure Chart
Wall Street Analyzer
Marketspace Chart
Time Series Forecast
Neural Network Prediction
Stock Options
Ultimate Trading Systems
Recommendation
Corporate Wepages
Company Profile |
Company History |
News |
Comparison |
Similar Companies Performance:
Bond Issue |
Zenith Index |
Zimmer Holdings Inc. (ZMH ) Sector: Healthcare
345 East Main Street Industry: Medical Appliances & Equipmen
Warsaw, IN 46580 Exchange: NYSE
Zimmer Holdings, Inc., through its subsidiaries, engages in the
design, development, manufacture, and marketing of orthopaedic and
dental reconstructive implants, spinal implants, trauma products,
and related surgical products in the Americas, Europe, and Asia
Pacific. The company offers orthopaedic reconstructive implants that
restore joint function lost due to disease or trauma in joints such
as knees, hips, shoulders, and elbows; dental reconstructive
implants, which restore function and aesthetics in patients who have
lost teeth due to trauma or disease; spinal implants that are used
by Orthopaedic surgeons and neurosurgeons in the treatment of
degenerative diseases, deformities, and trauma; and trauma products,
which are used primarily to reattach or stabilize damaged bone and
tissue to support the body-Ęs natural healing process. It also offers
surgical products, including supplies and instruments designed to
aid in orthopaedic surgical procedures and post-operation
rehabilitation. The company sells its products to musculoskeletal
surgeons, neurosurgeons, oral surgeons, dentists, hospitals,
stocking distributors, healthcare dealers and agents, and healthcare
purchasing organizations. It markets and sells its products through
healthcare institutions, such as hospitals or direct channel
accounts, stocking distributors, healthcare dealers, and dental
practices and dental laboratories. The company was founded in 1927
and is headquartered in Warsaw, Indiana.
Last Trade: 53.57 52-Week Range: 55.76 - 30.67
Trade Date: 10-30 Avg. Volume: 2,342,940 Shares
Index Membership: S&P 500 Employees: 8,000
Corporate Governance:
Zimmer Holdings Inc.'s Corporate Governance Quotient (CGQ-«) as of
1-Oct-09 is better than 91% of S&P 500 companies and 98.4% of Health
Care Equipment & Services companies.
EPS: 3.33 Dividend Amount: $ 0.00 Yield: 0.00%
Ex-Dividend Date: N/A Mkt Cap: $ 11,440,000K
Payout Ratio: 0.00%
Last Split Factor (new for old): N/A Split Date: N/A
Key Statistics:
Enterprise Value: $ 11,600,000K Revenue (ttm) : $ 4,020,000K
Gross Profit: $ 3,120,000K
Earnings before Income Tax, Depreciation and Amortization: $ 1,500,000K
Enterprise Value/Revenue (ttm): 2.89 Revenue per Share: $ 18.40
Enterprise Value/EBITDA (ttm): 7.73 Qtrly Rev Growth (y to y): 2.50%
P/E Ratio (fwd projected): 12.55 P/E Ratio (current): 16.08
P/E Growth Ratio (5 yr expected): 1.50 Operating Margin: 29.18%
Price/Sales Ratio: 2.85 Profit Margin: 18.16%
Price/Book Value: 1.91 Book Value: $ 27.99/sh.
Return on Assets: 9.95% Net Income Avl to Common: $ 729,700K
Return on Equity: 12.58% Diluted Earnings/Share: $ 3.33
Qrtly Earnings Growth (yoy): -30.20%
Balance Sheet Items : Cash Flow Items (ttm):
(most recent qrtr) (trailing 12 mo.)
Total Cash: $ 439,700K Operating Cash Flow:$ 938,900K
Total Debt: $ 600,200K Lvgd Free Cash Flow:$ 213,320K
Total Debt/Equity: 0.00
Total Cash/Share: $ 2.06
Current Ratio: 3.62
Share Statistics: Stock Price History:
Shares Outstanding: 213,600K Stk 52-Week Change: 20.44%
Float: 213,410K S&P 500 52-Wk Chng: 11.74%
Sh. Short % of Float: 1.90% 50-Day Moving Avg: 52.26
Short Ratio: 1.30 200-Day Moving Avg: 46.15
% Held by Institutions: 78.40% Beta: 1.11
% Held by Insiders: 0.07%
Analysts' Estimates: Cur. Qtr Next Qtr Cur. Year Next Year
___________________________ Dec-09 Mar-10 Dec-09 Dec-10
Average Earnings Estimate 1.08 1.02 3.90 4.27
Average Revenue Estimate 1,110M 1,070M 4,100M 4,360M
Factors Comparing This Company to Its Industry Leader (1.0 = Average):
Long Term EPS Growth Rate (5 yr): 0.208 EPS Growth (Qrtly YoY): -.050
PEG Ratio (ttm, 5 yr expected): 0.213 P/E Ratio (ttm): 0.086
Revenue Growth (Qrtly YoY): 0.000
Annual Income Statements: All numbers in thousands)
Period Ending 31-Dec-08 31-Dec-07 31-Dec-06
Total Revenue 4,121,100 3,897,500 3,495,400
Cost of Revenue 997,300 875,900 780,100
Gross Profit 3,123,800 3,021,600 2,715,300
Operating Expenses:
Research & Development 194,000 209,600 188,300
Selling, General & Administrative 1,702,300 1,489,700 1,355,700
Non-Recurring Expenses 137,500 194,700 6,100
Other Operating Expenses 0 0 0
Total Operating Expenses 0 0 0
Operating Income or Loss 1,090,000 1,127,600 1,165,200
Income from Continuing Operations:
Total Other Income/Expenses Net 31,800 4,000 3,800
Earnings Before Interest & Taxes 1,121,800 1,131,600 1,169,000
Interest Expense 0 0 0
Income Before Taxes 1,121,800 1,131,600 1,169,000
Income Tax Expense 272,300 357,900 334,000
Minority Interest -900 -500 -500
Net Income from Continuing Op.s 848,600 773,200 834,500
Non-recurring Events:
Discontinued Operations 0 0 0
Extraordinary Items 0 0 0
Effect of Accounting Changes 0 0 0
Other Items 0 0 0
Net Income 848,600 773,200 834,500
Preferred Stock & Other Adjustmnts 0 0 0
Net Income Avail To Common Shares 848,600 773,200 834,500
Quarterly Income Statements: All numbers in thousands)
Period Ending 30-Jun-09 31-Mar-09 31-Dec-08 30-Sep-08
Total Revenue 1,019,900 992,600 1,030,200 952,200
Cost of Revenue 236,800 230,300 243,100 237,200
Gross Profit 783,100 762,300 787,100 715,000
Operating Expenses:
Research & Development 49,900 51,800 47,200 46,700
Selling, General & Adminis. 425,300 430,700 435,600 404,900
Non-Recurring Expenses 11,400 0 64,600 53,100
Other Operating Expenses 0 0 0 0
Total Operating Expenses 0 0 0 0
Operating Income or Loss 296,500 279,800 239,700 210,300
Income from Continuing Operations:
Total Other Income/Expenses Net 0 0 -4,200 28,200
Earnings Before Int. & Taxes 296,500 279,800 235,500 238,500
Interest Expense 4,000 3,700 0 0
Income Before Taxes 292,500 276,100 235,500 238,500
Income Tax Expense 82,400 73,900 67,900 23,500
Minority Interest 0 0 -100 -300
Net Income from Continuing Op.s 210,100 202,200 167,500 214,700
Non-recurring Events:
Discontinued Operations 0 0 0 0
Extraordinary Items 0 0 0 0
Effect of Accounting Changes 0 0 0 0
Other Items 0 0 0 0
Net Income 210,100 202,200 167,500 214,700
Preferred Stock & Other Adj.s 0 0 0 0
Net Income Avail To Common Shs 210,100 202,200 167,500 214,700
Annual Balance Sheets: All Numbers in Thousands
Period Ending 31-Dec-08 31-Dec-07 31-Dec-06
Current Assets:
Cash & Cash Equivalents 215,300 466,400 268,100
Short Term Investments 0 0 0
Net Receivables 931,100 829,100 784,700
Inventory 928,300 727,800 638,300
Other Current Assets 103,900 59,400 55,100
Total Current Assets 2,178,600 2,082,700 1,746,200
Long-Term Investments 0 0 0
Property, Plant & Equipt 1,264,100 971,900 807,100
Goodwill 2,774,800 2,621,400 2,515,600
Intangible Assets 872,100 743,800 712,600
Accumulated Amortization 0 0 0
Other Assets 149,400 213,900 192,900
Deferred Long Term Asset Charges 0 0 0
Total Assets 7,239,000 6,633,700 5,974,400
Current Liabilities:
Accounts Payable 492,300 489,400 463,900
Short/Current Long Term Debt 17,700 50,000 0
Other Current Liabilities 261,100 209,200 164,300
Total Current Liabilities 771,100 748,600 628,200
Long Term Debt 460,100 104,300 99,600
Other Liabilities 353,900 328,400 323,400
Deferred LT Liability Charges 0 0 0
Minority Interest 3,600 2,800 2,700
Negative Goodwill 0 0 0
Total Liabilities 1,588,700 1,184,100 1,053,900
Stockholder Equity:
Misc. Stocks Options Warrants 0 0 0
Redeemable Perferred Stock 0 0 0
Preferred Stock 0 0 0
Common Stock 2,500 2,500 2,500
Retained Earnings 4,385,500 3,536,900 2,768,000
Treasury Stock -2,116,200 -1,379,200 -802,900
Capital Surplus 3,138,500 2,999,100 2,743,200
Other Stockholder Equity 240,000 290,300 209,700
Total Stockholder Equity 5,650,300 5,449,600 4,920,500
Net Tangible Assets 2,003,400 2,084,400 1,692,300
Quarterly Balance Sheets: All Numbers in Thousands
Period Ending 30-Jun-09 31-Mar-09 31-Dec-08 30-Sep-08
Current Assets:
Cash & Cash Equivalents 280,200 215,500 215,300 545,100
Short Term Investments 0 57,800 0 0
Net Receivables 985,800 929,800 931,100 888,800
Inventory 980,900 947,000 928,300 843,000
Other Current Assets 81,800 45,600 103,900 56,400
Total Current Assets 2,328,700 2,195,700 2,178,600 2,333,300
Long-Term Investments 0 24,800 0 0
Property, Plant & Equipt 1,254,400 1,257,200 1,264,100 1,188,000
Goodwill 2,814,600 2,754,100 2,774,800 2,649,200
Intangible Assets 874,600 857,800 872,100 713,700
Accumulated Amortization 0 0 0 0
Other Assets 189,800 142,300 149,400 194,600
Deferred LT Asset Charges 49,900 120,200 261,100 338,000
Total Assets 7,462,100 7,231,900 7,239,000 7,078,800
Current Liabilities:
Accounts Payable 619,300 583,400 492,300 478,700
Current Portion LT Debt 0 0 17,700 21,800
Other Current Liabilities 0 0 0 0
Total Current Liabilities 669,200 703,600 771,100 838,500
Long Term Debt 653,500 660,400 460,100 331,100
Other Liabilities 333,800 312,500 353,900 284,400
Deferred LT Liab. Charges 0 0 0 0
Minority Interest 0 0 3,600 3,500
Negative Goodwill 0 0 0 0
Total Liabilities 1,656,500 1,676,500 1,588,700 1,457,500
Stockholder Equity:
Misc. Options, WarrantS 0 0 0 0
Redeemable Perferred Stock 0 0 0 0
Preferred Stock 0 0 0 0
Common Stock 2,500 2,500 2,500 2,500
Retained Earnings 4,797,800 4,587,700 4,385,500 4,218,000
Treasury Stock -2,454,000 -2,417,600 -2,116,200 -2,068,100
Capital Surplus 3,176,900 3,154,100 3,138,500 3,114,200
Other Stockholder Equity 282,400 228,700 240,000 354,700
Total Stockholder Equity 5,805,600 5,555,400 5,650,300 5,621,300
Net Tangible Assets 2,116,400 1,943,500 2,003,400 2,258,400
Annual Cash Flow: All Numbers in Thousands
Period Ending 31-Dec-08 31-Dec-07 31-Dec-06
Net Income 848,600 202,200 834,500
Operating Activites:
Depreciation 275,100 230,000 197,400
Adjustments to Net Income 84,600 148,300 79,600
Changes in Accounts Recv'bls -44,400 -12,500 -76,900
Changes in Liabilities 42,000 68,000 -29,900
Changes in Inventories -148,100 -58,000 -39,200
Changes in Other Op'ing Actv's 0 -64,600 75,200
Total Cash Flow fr Operations 1,038,100 1,084,400 1,040,700
Investing Activities:
Capital Expenditures -487,900 -192,700 -268,300
Investments 54,900 0 0
Other Cash Flows fr Investing -491,200 -298,800 -18,700
Total Cash Flows fr Investing -924,200 -491,500 -287,000
Financing Acitivies:
Dividends Paid 0 0 0
Sale or Purchase of Stock -680,000 -426,500 -757,500
Net Borrowings 330,000 0 18,800
Other Cash Flows fr Financing 6,500 27,000 8,000
Total Cash Flows fr Financing -343,500 -399,500 -730,700
Effect of Exchange Rate Change -21,700 4,800 9,500
Change in Cash & Cash Equiv.s -251,300 198,200 32,500
Quarterly Cash Flow: All Numbers in Thousands
Period Ending 30-Jun-09 31-Mar-09 31-Dec-08 30-Sep-08
Net Income 210,100 202,200 167,500 214,700
Operating Activites:
Depreciation 81,800 79,600 79,100 66,800
Adjustments to Net Income -6,200 21,400 68,900 -19,000
Changes in Accounts Recv'bls -23,500 -6,300 -32,500 70,000
Changes in Liabilities -7,900 -111,500 -99,300 53,700
Changes in Inventories -19,600 -32,200 -44,800 -49,500
Changes in Other Oper'g Acts -39,600 31,400 68,000 -28,800
Total Cash Flow f Operations 195,100 184,600 206,900 307,900
Investing Activities:
Capital Expenditures -54,400 -76,200 -112,200 -134,700
Investments 0 0 54,900 0
Other Cash Flows fr Investing -35,500 -8,200 -527,500 31,800
Total Cash Flows fr Investing -89,900 -84,400 -584,800 -102,900
Financing Acitivies:
Dividends Paid 0 0 0 0
Sale or Purchase of Stock -36,100 -305,900 -45,300 -39,700
Net Borrowings -10,000 210,000 110,000 0
Other Cash Flows fr Financing 0 0 0 500
Total Cash Flows fr Financing 0 -4,100 -16,600 -11,500
Effect of Exchange Rate Chg 0 0 0 0
Change in Cash & Cash Equiv. 64,700 200 -329,800 154,300
ZMH Zimmer Holdings Inc. [Indices near +3.0 or near zero,
or < zero bear special attention.]
P/E Ratio Tests:
Current P/E Ratio < 28? 1.7413 P/E Ratio > 5? 1.0000
P/E Ratio Vs Growth Rate: 2.5000 Forward P/E Ratio < 28? 2.2311
Sales Tests:
Price/Sales Ratio < 2.3? 0.8070 Inventory/Sales < 5%? 0.2220
Sales < $1 billion? 0.2427 Operating Margin < 7.5%? 0.2570
Balance Sheet Tests:
Debt/Equity < 0.40? 1.0000 Long-Term Debt Service: 3.0000
LTD Being Reduced? 0.6000 Short-Term Debt Service: 3.0000
Current Ratio > 2? 1.8095 Working Capital >= 1.5? 0.5747
Leverage Ratio < 20%? 1.8628 Debt / Assets < 1? 3.0000
Quick Ratio > 1? 1.8918 Inventory Turnover > 1? 2.0158
Shares Out Decreasing? 1.8000 Market Cap.> 1.5 Billion? 0.1311
Profit Margin > 7.5%? 2.4213
Income Tests:
Dividend Yield > 2.0%? 0.0000 EPS Annual Growth > 10%? 0.0000
Enterprise Value/Revenue: 1.9267 EPS 5-yr Growth > 20%? 0.0000
Enterprise Value/EBITDA: 1.1040 EPS Growth Consistent? 1.8000
EPS Qrtly Growth > 10%? -3.0000 Collection < 45 days? 0.5457
Rev. Qtrly Growth > 15%? 0.3750 Gross Pft/Cur. LTD < 1? 3.0000
EPS Annual Growth > 10%? 0.0000 Borrowing Int. Rate< 6%? 3.0000
Stock Performance Tests:
Volatility > 25%? 2.3223 % Held by Insiders < 5%? 3.0000
Beta > 1.25? 0.8880 % Held by Institut. < 50? 0.6378
50 Da MA > 200 Da MA? 0.3422 % Held by Institut. > 30? 2.6133
52-Wk Change vs. S&P 500: 0.7827 Short Ratio > 5? 0.2600
Price/Book Value < 3? 2.0900 Short % of Float > 20? 0.0950
Return on Assets > 17%? 0.5853 Average Volume > 100,000? 3.0000
Cash Flow Tests:
Oper. C.F. > Lever'd C.F: 3.0000 Positive Free Cash Flow? 1.0000
Positive Oper. Cash Flow? 1.0000 Price to C.F./sh. Ratio: 3.0000
Cash Flow / Assets >.10? 0.2859
ZMH Zimmer Holdings Inc. Overall Zenith Index: 1.3433
Financial Statements |
Financial Ratios |
Market Grader |
Intrinsic Value |
Intrinsic Value by Discounted Cash Flow Method:
Intrinsic Value |
Intrinsic Value by Projected Earnings Growth Method:
Stock Scout |
We find "Scout" to be a bit biased toward the high end, so anything under a 6 is considered a negative, 6 and above, positive.
Projected Earnings |
Research Reports |
Analysts' Opinions |
Insider Activity |
Institutional Activity |
Institutional Orders to Buy or Sell:
Sentiment |
Zenith uses the "sentiment" score above or below 50 to award a positive or negative point in the Decision Matrix.
Short Interest Ratio |
As the short interest rises as a percentage of average daily share volume (Days to Cover), this is considered a measure of negative sentiment. Similarly, a decrease in that percentage is considered positive sentiment.
Stock Report |
Management's Discussion of Results of Operations Excerpts |
Moving Average Chart |
Channeling Potential |
The summary below includes a value for `Degree,' which refers on a
scale of 1 to 10 the range of a channel in the period under consi-
deration compared to the total range of price movement. It also looks
for the last closing price to be within the channel, otherwise zeroed.
The `Index' is the `Degree' weighted for volatility. Generally, the
the higher the index, the more suitable is the stock for trading as
a `rolling stock' between channel high and low points.
Results for Zimmer Holdings:
Symbol? ZMH
Total Months Available: 99
Months in Cycle? 4
Months Covered by Periods: 12
Period 1 Period 2 Period 3
H1 L1 H2 L2 H3 L3
46.92 34.10 47.41 30.67 55.76 38.55
RANGE = 55.76 TO 30.67 Close = 53.10
CHANNEL = 46.92 TO 38.55 Degree = 3
Volatility = 15.76% Index = 4
Intraday Chart |
20 Days:
1 Day:
The following table details which MACD signals on the preceding chart are best taken. Originally, this was set up for a two-day span, but ten days gives a better sample. Unfortunately, with the 10-day span, the colored lines on the histogram are much harder to read. Both spans are shown above. Red turning into green on the histogram is a buy and green turning into red is a sell, but with the following conditions. The share price must have moved at least 0.2% away from the previous signal price in order to avoid whipsawing. More importantly, the +/- magnitude of the MACD (the blue line, which crosses the red line at signal time) must be greater than the minimum required magnitude indicated below. Otherwise, the signal is ignored. This system works well for Zimmer. ZMH Minimum Magnitude MACD for Action = ± 0.0650 Ticker Day Time Hist. MACD Sig Line Act Price Profit ZMH 20 06:46 0.0062 -0.1462 -0.1525 B 51.37 0.00 ZMH 21 05:06 0.0249 0.1370 0.1121 51.30 6.25 ZMH 21 06:48 -0.0012 0.2152 0.2165 S 52.00 6.25 ZMH 21 07:01 0.0101 0.1546 0.1445 B 52.38 5.52 ZMH 21 07:20 -0.0167 0.3378 0.3545 S 53.25 7.18 ZMH 21 12:29 0.0001 -0.1109 -0.1110 B 52.49 8.61 ZMH 22 05:00 0.0780 0.0561 -0.0218 53.20 8.70 ZMH 22 06:47 -0.0284 0.2683 0.2968 S 53.36 8.70 ZMH 22 08:18 0.0000 0.0675 0.0675 B 54.07 7.37 ZMH 22 08:39 -0.0045 0.1561 0.1606 S 54.64 8.42 ZMH 22 09:33 0.0014 -0.0710 -0.0724 B 54.28 9.09 ZMH 22 10:20 -0.0032 0.0724 0.0756 S 54.53 9.56 ZMH 22 12:04 0.0007 0.0669 0.0661 B 54.97 8.75 ZMH 22 12:22 -0.0010 0.0730 0.0740 S 55.11 9.00 ZMH 22 14:54 0.0014 -0.0880 -0.0894 B 54.99 9.22 ZMH 23 06:05 0.0213 -0.0628 -0.0841 55.04 9.35 ZMH 23 08:49 -0.0010 -0.0719 -0.0710 S 54.81 9.35 ZMH 26 06:29 0.0515 0.0761 0.0246 55.13 9.38 ZMH 26 06:44 0.0036 0.1233 0.1197 B 55.23 9.38 ZMH 26 06:54 -0.0000 0.1623 0.1623 S 55.45 9.78 ZMH 26 08:49 0.0001 -0.1318 -0.1319 B 54.96 10.67 ZMH 26 09:00 -0.0048 -0.1083 -0.1035 S 54.72 10.23 ZMH 26 09:51 0.0049 -0.0844 -0.0893 B 54.48 10.67 ZMH 27 06:31 0.0056 0.0462 0.0405 54.25 11.53 ZMH 27 06:47 -0.0065 0.1694 0.1760 S 54.86 11.53 ZMH 27 12:44 0.0034 -0.0769 -0.0803 B 54.35 12.46 ZMH 28 06:31 -0.0038 -0.0278 -0.0241 54.17 13.71 ZMH 30 09:10 0.0251 -0.0129 -0.0381 53.04 13.71
Stock Fetcher |
Point & Figure Chart |
Wall Street Analyzer |
Marketspace Chart |
Time Series Forecast |
Neural Network Prediction |
"Neurostock" can only track long trades. Therefore its performance, as tracked by itself on stocks which are consistently falling, may not appear as good as it could if each "sell" signal were a "short sale."
Ultimate Trading Systems |
The corresponding trades for the above chart are shown in tabular form below.
Recommendation |
| Factors | Weighted Points |
|---|---|
| News | + 1 |
| Comparison | + 1 |
| Industry | - 1 |
| Bond Issue | 0 |
| Zenith Index | + 1 |
| GAAP vs. non-GAAP Earnings < 1% | + 1 |
| Cash Flow | + 1 |
| Ratios | + 1 |
| Market Grader | + 1 |
| Intrinsic Value DCF | + 1 |
| Intrinsic Value DDM | + 1 |
| Stock Scout | + 1 |
| Projected Earnings | + 1 |
| Research Reports | + 1 |
| Analysts | - 1 |
| Executive Perquisites | + 1 |
| Insider Activity | - 1 |
| Institutional Activity | - 1 |
| Management Reporting | + 1 |
| Short Interest | - 1 |
| Sentiment | + 1 |
| Standard & Poor's | + 1 |
| Moving Average | + 1 |
| Stock Fetcher | - 1 |
| Point & Figure | + 1 |
| Wall Street Analyzer | - 1 |
| Marketspace Chart | + 1 |
| Time Series Chart | - 1 |
| Neural Network | 0 |
| Stock Options | + 1 |
| Ultimate Trading Systems | + 1 |
| Total | + 13 |
Place 565 shares of Zimmer Holdings Inc. (ZMH) on the Active List.
